Format

Send to:

Choose Destination
See comment in PubMed Commons below
Z Geburtshilfe Neonatol. 2014 Aug;218(4):171-3. doi: 10.1055/s-0034-1382069. Epub 2014 Aug 15.

Successful treatment of 1-34 parathyroid hormone (PTH) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures.

Author information

  • 1Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis, Phillipps-University of Marburg, Marburg, Germany.
  • 2Department of Obstetrics and Gynecology, Philipps-University of Marburg, Germany.
  • 3Department of Endocrinology, Reproductive Medicine and Osteoporosis, Krankenhaus Nordwest, Frankfurt, Germany.

Abstract

INTRODUCTION:

Pregnancy associated osteoporosis (PAO) was first reported almost half a century ago. The most common symptom is acute lower back pain due to vertebral fractures in the last trimester or immediately after birth.

PATIENT:

We present a case involving a female patient born in 1971 (gravida II, para I) with a history of PAO. In April 2000 at the age of 28 years, she delivered a son and breastfed him for 4 months. A first magnetic resonance tomography (MRT) screening in June 2000 showed osteoporotic fractures at lumbar vertebra 1-4. Therefore, the patient received oral alendronate therapy. In May 2001, a second MRT exhibited burst fracture of thoracic 8, end-plate fracture of thoracic 11, 12, lumbar 2-5 and compression fracture of lumbar 1. The oral therapy was switched to ibandronate (3 mg) intravenously every 3 months. An X-ray in December 2002 showed 3 new additional end-plate fractures at thoracic 4, 6 and 7. Ibandronate was discontinued in September 2004 and the patient received daily subcutaneous (s. c.) injections of 1-34 PTH in September 2005.

RESULTS:

After starting 1-34 PTH treatment for 18 months, a further increase in bone mineral density (BMD) was achieved without any further fracture.

CONCLUSION:

We presented for the first time a case of severe PAO with 11 spine fractures. We observed an unsatisfactory effect of oral and i. v. bisphosphonates in combination with adequate calcium and vitamin D supplementation. The treatment with 1-34 PTH showed an increase in BMD with no further fractures.

© Georg Thieme Verlag KG Stuttgart · New York.

PMID:
25127351
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Write to the Help Desk